CATEGORIES: Bike New York | CMT Update

Calling All Cyclists… Enjoy NY Sights While Riding to Cure CMT!

by | Mar 10, 2015 | 0 comments

Bike NY PictureHereditary Neuropathy Foundation (HNF) is excited to participate for the fourth consecutive year in the TD Bank Five Boro Bike Tour. It’s an honor says Allison Moore, Founder/CEO of HNF to once again be chosen as a charity partner in one of the biggest events in New York and the largest cycling event in America.

The event provides participants the unique and fun experience to bike through all five boroughs – a 42-mile, traffic-free ride for 32,000 cyclists. Starting just north of Battery Park, the tour runs up Manhattan, through Central Park, around a brief loop in the Bronx and down to the Queensboro Bridge passing countless New York City icons on the way. After a ride over the Pulaski Bridge passing through Brooklyn, riders enjoy an incredible view from the lower deck of the Verrazano Bridge. HNF Riders will get VIP treatment, which includes breakfast and lunch as well as priority start, special bike parking at the start, and a Team CMT singlet.

100% of all donations will go towards HNF’s Therapeutic Research in Accelerated Discovery (TRIAD) program for Charcot-Marie-Tooth. Click here for more information and to register.

Learn more on this topic

Related Blog Posts

Building Awareness on CMT and Supporting the Patient Community – HNF Announces Support from Pharnext

HNFpharnext recently entered into a partnership with the French biopharmaceutical company, Pharnext, to help raise awareness of Charcot-Marie-Tooth (CMT) disease and support the CMT patient community through several initiatives. Building awareness is key! Pharnext’s support will assist HNF in distributing HNF’s CMT Update quarterly newsletter, enhancing the Global Registry for Inherited Neuropathies (GRIN), setting up activities for CMT September Awareness Month in the US and strengthening the CMT Inspire Community.

In Memoriam

The HNF family has lost two great people this summer: Franklin G. Downing Sr. (father of board member Matthew Downing) and George G. Gatta (father of board member Kathleen Zappola).

Targeting PMP22 in CMT1A Patients with Gene Duplication

In previous collaborative work with a group of investigators including Dr Rolf Renne from the University of Florida, Dr. Alex Murashov from East Carolina University and Dr. Lynn Hudson from the NIH-NINDS, we validated a microRNA known as miR29a as a reagent that corrected the expression level of PMP22 in rodent Schwann cells.

Join the conversation

Leave a Comment

0 Comments

Submit a Comment

Your email address will not be published. Required fields are marked *

Newsletter

Join for notifications on events, campaigns, & news